Intellia Therapeutics Inc... (NTLA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
10.27
-0.28 (-2.65%)
At close: Jan 28, 2025, 3:04 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
PE Ratio | -5.62 | -5.48 | -32.28 | -24.26 | -7.48 | -6.89 | -10.25 | -9.21 | -31.49 | -0.75 |
PS Ratio | 74.61 | 51.53 | 253.61 | 52.52 | 16.08 | 19.32 | 26.50 | 17.68 | 64.59 | n/a |
PB Ratio | 2.58 | 2.17 | 8.06 | 5.78 | 2.57 | 2.12 | 2.30 | 1.39 | 5.80 | 1.42 |
P/FCF Ratio | -6.63 | -6.86 | -35.25 | -56.93 | -6.3 | -8.69 | -9.18 | 9.73 | -90.43 | -2.76 |
P/OCF Ratio | -6.87 | -8.06 | -37.25 | -61.02 | -6.71 | -9.6 | -10.6 | 8.07 | -221.43 | -3.08 |
OCF/S Ratio | -10.86 | -6.39 | -6.81 | -0.86 | -2.4 | -2.01 | -2.5 | 2.19 | -0.29 | n/a |
Debt / Equity Ratio | 0.11 | 0.11 | 0.07 | 0.07 | 0.07 | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 8.67 | 10.16 | 8.79 | 9.59 | 8.12 | 8.01 | 11.32 | 9.15 | 7.26 | 4.30 |
Current Ratio | 8.67 | 9.61 | 6.11 | 9.30 | 8.12 | 8.01 | 11.32 | 9.15 | 7.26 | 4.30 |
Asset Turnover | 0.03 | 0.03 | 0.03 | 0.09 | 0.13 | 0.09 | 0.07 | 0.06 | 0.07 | n/a |
Interest Coverage | n/a | -53.64 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -0.46 | -0.4 | -0.25 | -0.24 | -0.34 | -0.31 | -0.22 | -0.15 | -0.18 | -1.89 |
Return on Assets (ROA) | -0.37 | -0.32 | -0.2 | -0.19 | -0.28 | -0.25 | -0.18 | -0.11 | -0.15 | -1.34 |
Return on Capital (ROIC) | -0.43 | -0.33 | -0.23 | -0.22 | -0.36 | -0.3 | -0.2 | -0.12 | -0.19 | -0.63 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 75.26% | 85.47% | 79.15% | -159.35% | -151.52% | -192.81% | -159.02% | -93.22% | -84.81% | n/a |
Net Profit Margin | -1.33K% | -940.52% | -785.76% | -216.52% | -215.06% | -280.42% | -258.62% | -191.97% | -205.11% | n/a |
Pretax Profit Margin | -1.33K% | -909.78% | -810.49% | -231.46% | -230.92% | -280.42% | -258.62% | -191.97% | -221.86% | n/a |
Operating Profit Margin | -1.42K% | -879.04% | -810.37% | -235.51% | -246.78% | -298.58% | -266.32% | -195.15% | -221.86% | n/a |
FCF Margin | -1.12K% | -751.48% | -719.41% | -92.25% | -255.28% | -222.17% | -288.57% | 181.71% | -71.43% | n/a |
EBITDA Margin | -1.40K% | -864.51% | -789.52% | -224.63% | -233.81% | -283.91% | -254.86% | -188.45% | -216.43% | n/a |